Showing results (21-30 of 110) with videos related to
Sort By:
Pageof 11
International Journal of Endocrinology|November 18, 2020
Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot StudyAlessandro Rossini, Sofia Frigerio, Elena Dozio, et al.Journal of Cardiovascular Pharmacology|November 26, 2003
Nephroprotective effect of bosentan in diabetic ratsAlessandro Cosenzi, Elena Bernobich, Roberto Trevisan, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2011
Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) studyGiuseppe Pugliese, Anna Solini, Cecilia Fondelli, et al.The Journal of Thoracic and Cardiovascular Surgery|September 4, 2012
Inspiratory muscle training for diaphragm dysfunction after cardiac surgeryMetka Kodric, Roberto Trevisan, Chiara Torregiani, et al.Trials|May 22, 2024
Telemedicine home-based management in patients with chronic heart failure and diabetes type II: study protocol for a randomized controlled trialPalmira Bernocchi, Vittorio Giudici, Gabriella Borghi, et al.Acta Diabetologica|December 3, 2025
Once-weekly administration of insulin in the real-world management of type 2 diabetes. A Delphi-like consensusRiccardo Candido, Raffaella Buzzetti, Agostino Consoli, et al.The Journal of Clinical Endocrinology and Metabolism|November 22, 2023
Development of a New Model of Insulin Sensitivity in Patients With Type 2 Diabetes and Association With MortalityStefano Ciardullo, Alessandro Roberto Dodesini, Giuseppe Lepore, et al.Diabetes Care|January 28, 2003
Renal and metabolic effects of insulin lispro in type 2 diabetic subjects with overt nephropathyPiero Ruggenenti, Claudio Flores, Claudio Aros, et al.Plos One|December 25, 2013
Off-patent generic medicines vs. off-patent brand medicines for six reference drugs: a retrospective claims data study from five local healthcare units in the Lombardy Region of ItalyGiorgio L Colombo, Enrico Agabiti-Rosei, Alberto Margonato, et al.Acta Diabetologica|July 20, 2022
Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose controlGiuseppe Lepore, Alessandro Rossini, Rosalia Bellante, et al.Pageof 11